Ingredient or product comparison
Wrinkles Peptides 2026 Update: Peptide Comparison
GHK-Cu (copper peptide) Copper transport to fibroblasts for collagen cross-linking via lysyl oxidase activation 18% dermal thickness increase over 12 weeks (British Journal of Dermatology 2026) 1–2% Anhydrous base or cyclodextrin encapsulation to prevent coppe
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu (copper peptide)
- Copper transport to fibroblasts for collagen cross-linking via lysyl oxidase activation
- 18% dermal thickness increase over 12 weeks (British Journal of Dermatology 2026)
- 1–2%
- Anhydrous base or cyclodextrin encapsulation to prevent copper oxidation
- Most robust evidence for structural remodelling. Requires stable formulation to remain effective
- Palmitoyl tetrapeptide-7
- IL-6 inhibition reduces MMP-1 expression and collagen degradation
- 27% procollagen I synthesis increase over 16 weeks (JAMA Dermatology 2026)
- 3–5%
- Lipid carrier (ceramides or phospholipids) for dermal penetration
- Strongest collagen synthesis signal. Ineffective below 2% concentration
- Acetyl hexapeptide-8
- SNARE complex inhibition reduces acetylcholine release and muscle contraction
- 31% wrinkle depth reduction over 12 weeks with encapsulated formulation (Journal of Cosmetic Dermatology 2026)
- 5–10%
- Phospholipid encapsulation, pH 5.0–5.5, refrigeration post-opening
- Effective for expression wrinkles only. Not a Botox replacement, requires continuous use
- Palmitoyl tripeptide-1 (Matrixyl)
- TGF-beta stimulation increases fibroblast collagen synthesis
- 19% collagen increase alone; 34% when combined with palmitoyl tetrapeptide-7 (2026 synergy study)
- 3–8%
- Stable in most bases; works best in combination formulations
- Well-studied but less potent alone. Synergistic with palmitoyl tetrapeptide-7